Valuation: Compumedics Limited

Market Cap 4.79Cr 3.37Cr 3.01Cr 2.78Cr 2.52Cr 4.72Cr 320.1Cr 33Cr 13Cr 167.71Cr 13Cr 12Cr 528.75Cr P/E 2027 *
11.4x
P/E 2028 * 7.5x
Enterprise Value 4.79Cr 3.37Cr 3.01Cr 2.78Cr 2.52Cr 4.72Cr 320.1Cr 33Cr 13Cr 167.71Cr 13Cr 12Cr 528.75Cr EV / Sales 2027 *
0.63x
EV / Sales 2028 * 0.53x
Free-Float
36.04%
Yield 2027 *
-
Yield 2028 * -
3 months+4.35%
6 months-18.64%
Current year-28.36%
1 week 0.24
Extreme 0.24
0.25
1 month 0.23
Extreme 0.23
0.28
Current year 0.22
Extreme 0.215
0.45
1 year 0.22
Extreme 0.215
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.45
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 16/12/2010
Director of Finance/CFO 61 11/11/2009
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 16/12/2010
Director/Board Member 61 01/01/2000
Director/Board Member - 27/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-40.00%+54.84% 3.36Cr
-0.67%-2.74%+17.34%+45.31% 25TCr
-1.20%-0.85%+1.96%+11.29% 16TCr
+2.19%+5.98%-17.98%+65.89% 15TCr
-0.74%+2.29%-55.65%-9.43% 6.67TCr
+0.24%+0.99%-15.19%-10.88% 5.21TCr
+0.34%+4.21%+10.96%+65.76% 5.22TCr
-0.43%+3.50%+17.12%+29.80% 5.19TCr
-1.24%-0.77%+16.39%+56.97% 4.9TCr
-0.68%+3.45%+27.08%+76.80% 4.48TCr
Average -0.26%+1.35%-3.80%+38.64% 8.82TCr
Weighted average by Cap. -0.21%+0.55%+0.98%+37.76%

Financials

2027 *2028 *
Net sales 7.56Cr 5.32Cr 4.75Cr 4.39Cr 3.98Cr 7.44Cr 504.76Cr 53Cr 21Cr 264.46Cr 20Cr 20Cr 833.77Cr 9.1Cr 6.4Cr 5.72Cr 5.28Cr 4.78Cr 8.95Cr 607.58Cr 64Cr 25Cr 318.33Cr 24Cr 24Cr 1TCr
Net income 60L 42.2L 37.68L 34.81L 31.55L 59.02L 40Cr 4.19Cr 1.66Cr 21Cr 1.58Cr 1.55Cr 66Cr 92L 64.71L 57.78L 53.38L 48.37L 90.5L 61Cr 6.42Cr 2.54Cr 32Cr 2.43Cr 2.38Cr 101.46Cr
Net Debt - -
Projected Income Statement - Annual - Compumedics Limited
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
23/26/23 A$0.2400 0.00% 70,185
22/26/22 A$0.2400 -4.00% 6,350
21/26/21 A$0.2500 +2.04% 1,27,536
20/26/20 A$0.2450 +2.08% 4,040
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Compumedics Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2400AUD
Average target price
0.6500AUD
Spread / Average Target
+170.83%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Compumedics Limited